DUBLIN--(BUSINESS WIRE)--The "Global Stroke Management Market Analysis & Trends - Industry Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
The Global Stroke Management Market is poised for strong growth during the forecast period 2017 to 2027.
Some of the prominent trends that the market is witnessing include increasing geriatric population and rise in incidences of chronic diseases.
This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world, the report is a valuable asset for the existing players, new entrants and future investors.
Key Topics Covered:
1 Market Outline
2 Executive Summary
3 Market Overview
4 Stroke Management Market, By Type
5 Stroke Management Market, By Application
6 Stroke Management Market, By Geography
7 Key Player Activities
8 Leading Companies
- GE Healthcare
- Boston Scientific Corp.
- Abbott Laboratories
- Medtronic Plc.
- Siemens Healthcare
- Merck & Company.
- B Braun Melsungen AG
- Cardinal Health
- Glaxosmithkline Plc.
- Bristol-Myers Squibb
- Koninklijke Philips N.V.
- Cordis Corporation
- Stryker Corporation
- Genentech, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/dn8fzv/global_stroke?w=4
